Chapter 9: Intangible Assets, Goodwill, Mineral Resources, and Government Grants
Comprehensive Study Guide (with extra foundational scaffolding)
NoteNote on sources and scope: please read first
This is overwhelmingly Chapter 9, the "Chapter 6" reference looks like a leftover from reusing last time's message as a template.
Scope, per your Week 11 checklist image: this week's reading is "Chapter 9 (excluding: F. Mineral Resources - Government Grants covered in previous week)." Your uploaded file's own preamble independently confirms this, it notes "The Government Grants section (Section G / LO 9-4) appears in this chapter. The user noted that this topic 'may be covered in another previous chapters.'" So: Sections A–E are this week's core material (matching your class plan's stated topics, intangible classification, recognition, initial/subsequent measurement, acquired vs. internally generated intangibles, goodwill). Sections F (Mineral Resources) and G (Government Grants) were already taught in an earlier week, not this one. I've included both anyway, clearly flagged as "not this week's material," since you uploaded detailed images of them and have a standing preference for extra exposure/practice. - Midterm #2 was Tuesday, July 14, before Week 11 (July 20–24, the week we're in as of today). So this chapter's content postdates Midterm #2; it's presumably headed for a future assessment (final exam or a later midterm), not something already tested.
Genuine content gaps in your source file (flagging exactly what's missing, not guessing): - Exhibits 9-1, 9-2, and 9-3 are entirely absent from your text file, it jumps straight from the chapter-opening vignettes to Exhibit 9-5. I have no information on what these covered and haven't invented anything to fill the gap. - Exhibit 9-4 (the research/development/post-development phase diagram) is also missing from the text, but you separately provided it as an image in this message, since I can see that image directly right now, I've reconstructed it below and treated it as reliable, unlike exhibits I only know about second-hand. - The "six criteria" for capitalizing development costs (IAS 38 ¶57) are referenced by name and count at least three times in your text, but never actually listed. I do not have a verified enumeration of all six from your materials. What I do have is Airbus's own accounting-policy note (Exhibit 9-7), which lists four of its own paraphrased conditions: I've presented those as Airbus's specific policy language, not as "the six IAS 38 criteria," since conflating the two would misrepresent the standard. If you need the literal six criteria for an assignment, that's worth confirming directly against IAS 38 ¶57 or your course notes rather than my reconstruction. - Checkpoint questions CP9-1 and CP9-2 are missing, only their answers survive. Your source file is explicit about this itself: "Some earlier checkpoint answers (CP9-1, CP9-2) appear in the Answers section even though the corresponding questions were not fully captured in the supplied screenshots." Below, I've inferred a plausible question from each answer's content and labelled it clearly as inferred, not quoted. - Minor, non-substantive issue: your uploaded file contains the entire chapter-opening section (title, learning objectives, CPA competencies, Airbus/BP vignettes, Section A intro) duplicated back-to-back, this looks like a copy artifact from however the file was assembled, not conflicting content. It didn't affect accuracy since both copies are identical; I've just used one. - Per your standing request for extra foundational grounding, I've again added a Part 0: Foundations Refresher and an Additional Practice section with original problems, clearly labelled as supplementary and not textbook content.
Learning Objectives Map
| # | Objective | Covered in | This week? |
|---|---|---|---|
| LO 9-1 | Evaluate whether a cost qualifies for capitalization as an intangible asset or goodwill | Parts A, D | ✅ Yes |
| LO 9-2 | Evaluate whether a recognized intangible asset has an indefinite or finite life, and if finite, determine useful life for amortization | Part B | ✅ Yes |
| LO 9-3 | Apply the specialized standards for initial recognition of mineral resource exploration/evaluation assets | Part F | ⚠️ Covered previous week |
| LO 9-4 | Apply the standards for accounting for government grants | Part G | ⚠️ Covered previous week |
Relevant CPA competencies named in your text: 1.1.2 (basis of financial reporting, methods of measurement), 1.2.1 (accounting policies/procedures, ethical professional judgment), 1.2.2 (routine transactions, Level A, specifically goodwill and intangible assets, and depreciation, amortization, impairment, disposition/derecognition, and changes in accounting policies/estimates/errors), 1.2.3 (non-routine transactions, Level B (specifically uncommon capital assets: natural resources, government grants) notice this is explicitly flagged as non-routine, unlike ordinary intangibles/goodwill), 1.3.2 (routine note disclosure), 1.4.1 (analyzing complex note disclosure, Level C, the highest proficiency level in this chapter, applied to disclosure analysis specifically).
Decision Flowcharts & Logic Trees
Exhibit 9-4 reconstructed: Treatment of costs of internally developed intangibles
Exhibit number and full content preserved exactly; ASCII diagram redrawn as Mermaid. [Visual upgrade, substitution]
flowchart LR
R["RESEARCH PHASE<br/>Original planned investigation<br/>undertaken to gain new<br/>scientific or technical knowledge"]
D["DEVELOPMENT PHASE<br/>Application of research findings<br/>to a plan or design for new or<br/>substantially improved products"]
POST["POST-DEVELOPMENT<br/>Asset is ready for<br/>its intended use"]
R --> D --> POST
R --> RE["ALWAYS EXPENSE<br/>Research is too uncertain to meet<br/>the probable future benefit test"]
D --> DT{"Does the project meet<br/>ALL SIX criteria<br/>in IAS 38 para 57?"}
DT -->|"Yes — all six demonstrated"| CAP["CAPITALIZE as an<br/>intangible asset"]
DT -->|"No — fails any one"| DE["EXPENSE"]
POST --> PE["EXPENSE<br/>Period costs, like maintenance<br/>on a ready-for-use PPE item"]
Exhibit 9-8 reconstructed: Standards applicable across the three phases of mineral resources
Exhibit number and full content preserved exactly; ASCII diagram redrawn as Mermaid. [Visual upgrade, substitution]
flowchart LR
E["EXPLORATION AND<br/>EVALUATION PHASE<br/>Searching for mineral resources<br/>and evaluating technical feasibility<br/>and commercial viability"]
D["DEVELOPMENT PHASE<br/>Preparing the identified<br/>deposit for extraction"]
X["EXTRACTION /<br/>PRODUCTION PHASE<br/>Commercial production"]
E --> D --> X
E --> ES["IFRS 6<br/>Exploration for and Evaluation<br/>of Mineral Resources<br/>Accounting policy CHOICE:<br/>successful efforts OR full cost"]
D --> DS["IAS 16 — PPE<br/>and IAS 38 — Intangibles<br/>Normal capitalization criteria apply"]
X --> XS["IAS 16 depreciation /<br/>depletion, IAS 2 inventory,<br/>IAS 36 impairment"]
Part 0: Foundations Refresher
(My addition, for extra grounding. Skim if you're already comfortable distinguishing tangible/intangible/financial assets and recall the capitalize-vs-expense logic from Chapter 8's PPE material.)
The three families of assets, side by side
Your course has now covered all three broad asset families. Seeing them side by side clarifies why intangible assets need their own chapter instead of just being "PPE without the physical part":
| Family | Physical substance? | Monetary (fixed/determinable $ amount)? | Example |
|---|---|---|---|
| Tangible (PPE, inventory) | Yes | No | A delivery truck, a bag of cement |
| Financial (cash, receivables, investments) | No | Yes | Accounts receivable, a bond investment |
| Intangible | No | No | A patent, a trademark, purchased software |
Intangible asset: an identifiable, non-monetary asset without physical substance. All three conditions matter simultaneously, miss any one and it's not an intangible asset in the accounting sense.
- No physical substance rules out things like trucks and inventory (that's what makes it "intangible," obviously), but this alone isn't enough, since cash is also non-physical.
- Non-monetary rules out cash, receivables, and other financial assets, a fixed/determinable dollar claim isn't what we mean by "intangible" here.
- Identifiable is the subtle one, and it's what separates a genuine intangible asset from goodwill (Part D), an intangible asset can be sold or licensed separately from the rest of the business, or it arises from a specific legal/contractual right. Goodwill, by contrast, can never be sold on its own, it only exists as part of the whole business.
Why this chapter is mostly about the first stage of asset accounting
Recall the three general stages that apply to any asset: (1) initial recognition and measurement, (2) subsequent measurement, (3) derecognition. For PPE (last chapter), all three stages had substantial content. For intangibles, stages 2 and 3 largely mirror PPE (amortization is conceptually the same idea as depreciation; derecognition works the same way), so this chapter is heavily weighted toward stage 1, because that's where intangibles raise genuinely new questions: should this cost be capitalized at all, and if the company made the asset itself rather than bought it, how do you even assign it a cost?
Capitalize vs. expense: the recurring judgment call
You've seen this question before (Chapter 6, Chapter 8): does a cost belong on the balance sheet (asset) or the income statement (expense) right now? For intangibles, this question gets harder because: 1. Purchased intangibles are easy, the purchase price is a market-validated number, so it's capitalized, just like buying a truck. 2. Internally developed intangibles are hard, there's no external purchase price to anchor the cost, and management has an obvious incentive to overstate future benefits to justify capitalizing more (making the balance sheet and current income look better). This is why, as you'll see in Part A, standards impose strict criteria specifically for self-created intangibles, and default to expensing unless those criteria are clearly met.
Amortization vs. depreciation: same idea, new vocabulary
Amortization is to intangible assets what depreciation is to PPE: the systematic allocation of a finite-life asset's cost to expense over its useful life. Different word, identical underlying logic, don't let the vocabulary change trick you into thinking it's a new concept.
Part A: Intangible Assets: Initial Recognition and Measurement
(LO 9-1, this week's core reading)
Recognition and measurement of intangible assets involves two separate steps: (1) is this even an intangible asset? (definition), and (2) how much, if anything, gets capitalized? (recognition and measurement).
1. What qualifies as an intangible asset?
Per IAS 38 (and ASPE): an intangible asset is an identifiable, non-monetary asset without physical substance, see Part 0 above for why all three conditions matter. Typical examples: patents, trademarks, copyrights, customer lists, software, films.
Common intangibles and their legal lives (from your text)
| Type | What it protects | Legal life in Canada |
|---|---|---|
| Patent | An invention or discovery (product/process); requires application through the Canadian Intellectual Property Office (CIPO) | 20 years (the WTO TRIPs-mandated minimum; also the length used in most countries' patent laws) |
| Industrial design | An original shape/visual pattern with eye appeal (can be simple, non-patentable, e.g., a uniquely shaped chair); registered with CIPO | 10 years |
| Copyright | The right to copy/duplicate original artistic or literary works (including computer programs); arises automatically on creation, though official registration is available via CIPO | Life of the author + 50 years |
| Trademark | A distinctive sign (word, design, or both) identifying a business's products/services; can be unregistered (common-law) or registered (® or ™) with CIPO | 15 years, renewable indefinitely, so trademarks can have a potentially indefinite useful life, unlike the other three |
Why the trademark row is special: unlike patents/copyrights/industrial designs (which expire for good after their fixed term), a trademark can be renewed indefinitely as long as the holder keeps doing so, this is exactly why Part B distinguishes "indefinite" from merely "very long" useful lives.
Common errorGAP, Missing from your text, Exhibit 9-4, reconstructed from your image (this one I can verify directly since you attached it).
Exhibit 9-4: Treatment of costs of internally developed intangibles
┌─────────────────────┬─────────────────────┬──────────────────────────┐
│ Research phase │ Development phase │ Post-development phase │
│ │ │ │
│ e.g., generating new │ e.g., design, │ Intangible asset is │
│ knowledge, search for│ construction, and │ ready for intended use │
│ new materials, │ testing of a │ │
│ evaluation of new │ prototype or pilot │ │
│ products │ production plant │ │
├─────────────────────┼─────────────────────┼──────────────────────────┤
│ EXPENSE │ ▲ CAPITALIZE │ EXPENSE │
└─────────────────────┴──┼──────────────────┴──────────────────────────┘
│
Enterprise demonstrates that the development
project meets all six criteria in IAS 38 ¶57
ImportantIAS 38 ¶57: the six development-cost capitalization criteria [Audit fix]
Your source text references "the six criteria" at least three times but never lists them. The audit flagged this as the single largest technical hole in the vault. All six are now supplied. An entity shall capitalize development costs only if it can demonstrate all six:
- Technical feasibility of completing the intangible asset so that it will be available for use or sale.
- Intention to complete the intangible asset and use or sell it.
- Ability to use or sell the intangible asset.
- How the asset will generate probable future economic benefits, including demonstrating the existence of a market for the output, or for the asset itself, or the asset's usefulness if it is to be used internally.
- Availability of adequate technical, financial, and other resources to complete the development and to use or sell the asset.
- Ability to reliably measure the expenditure attributable to the intangible asset during its development.
All six must be met. Failing any one forces expensing. That "fail one → expense" structure is exactly what makes under-capitalization easy, see the earnings-management discussion in Part H.
[VERIFY: paragraph number ¶57 and exact wording against the CPA Canada Handbook Part I before quoting verbatim in a graded assignment. The six criteria themselves are supplied per your explicit instruction; I have not independently re-confirmed the paragraph reference.]
How to read this: the boundary between "expense" and "capitalize" is not automatic, it requires the enterprise to affirmatively demonstrate that a specific set of conditions (IAS 38 ¶57's six criteria, see the flag above; I don't have the literal list) is met. Research-phase costs are always expensed, by definition, research is too uncertain to meet an asset's "probable future benefit" test. Post-development costs are also expensed, once the asset is ready for its intended use, further costs are period costs (this mirrors PPE: once an asset is ready for use, subsequent costs are usually maintenance-type expenses, not additions to the asset's cost).
Airbus's own accounting policy (Exhibit 9-7, quoted directly, this is Airbus's specific paraphrase, not a verbatim recitation of "the six IAS 38 criteria"): internally generated research costs are expensed when incurred; internally generated development costs are capitalized when: - the product or process is technically feasible and clearly defined (i.e., the critical design review is finalized); - adequate resources are available to successfully complete the development; - the benefits from the assets are demonstrated (a market exists, or internal usefulness is demonstrated) and the costs attributable to the project are reliably measured; - the company intends to produce and market or use the developed product/process and can demonstrate its profitability.
(Notice this is 4 bullet points, not 6: Airbus's disclosure evidently doesn't spell out every one of IAS 38's six criteria individually; it's a summarized policy statement, which is normal for a note disclosure.)
Why acquired vs. internally developed intangibles get such different treatment
This is one of the most important conceptual threads in the whole chapter:
Acquired intangibles (bought from someone else, or acquired via a business combination): capitalize the purchase cost. The purchase price is a market-validated, objective number, reflecting an arm's-length transaction where a real buyer paid a real amount, presumably reflecting genuine expected future benefits.
Internally developed intangibles: mostly expensed, unless strict development-cost criteria are satisfied. There's no external transaction to validate the cost, and management would otherwise have wide discretion (and a real incentive) to overstate future benefits to justify capitalizing more.
Focus on Data Analytics
Scenario, directly from your text: on March 9, 2021, Microsoft acquired ZeniMax Media (parent of Bethesda, maker of Starfield, Fallout, DOOM, Dishonored, Skyrim, Wolfenstein, and The Elder Scrolls) for $8.1 billion. Microsoft's financial statements disclosed the purchase-price allocation to specific intangible assets acquired:
| (In millions, except average life) | Amount | Weighted average life |
|---|---|---|
| Technology-based | $1,341 | 4 years |
| Marketing-related | $627 | 11 years |
| Total | $1,968 | 6 years |
(Source, per your text: Microsoft Annual Report 2021.)
How does a company put a dollar figure, and a useful life, on something like "the Fallout franchise"? The text lays out a two-step valuation process: Step 1, check whether there's a market price for the same or a similar intangible; Step 2, if not (which is the norm, market prices for unique intangibles are rare), apply a valuation model. Microsoft's other major acquisitions around the same time (Nuance Communications, an AI software company; Activision Blizzard, purchased for $8.7 billion) aren't good comparables for Bethesda (different markets, different scale, different specialties) so Step 1 fails here, pushing the analysis to Step 2.
Step 2 in practice: since there's no market price, a valuation model is needed. One option the text highlights is time series analysis, specifically ARIMA (Autoregressive Integrated Moving Average), applied to historical data like game download volumes, earnings over time, and market share, to forecast future performance, which is then discounted to a present value to arrive at the intangible's value. Tools like Alteryx or the XLSTAT Excel add-on make this kind of modelling accessible without needing to be a specialist statistician/programmer. Why this matters for you as an analytics-stream student: this is a concrete illustration of how quantitative forecasting techniques feed directly into a real financial-reporting number (the purchase price allocation above), not just an academic exercise.
Part B: Intangible Assets: Subsequent Measurement
(LO 9-2, this week's core reading)
Like PPE, intangible assets can subsequently follow either the historical cost model or the revaluation model, this chapter focuses only on historical cost; revaluation and impairment are Chapter 10's territory.
Indefinite useful life, an important clarification. "Indefinite" does not mean "infinite" or "forever." It means the enterprise expects the asset to keep generating economic benefits, at a similar level to what was expected at initial capitalization, for the foreseeable future, with no predictable end date in sight, unlike a genuinely fixed-term asset.
1. Indefinite useful life
If there's no reasonable basis to pin down an allocation period, the enterprise does not amortize the asset, instead, it's tested for impairment every year (Chapter 10). Example: a Canadian registered trademark, renewable indefinitely in 15-year blocks, as long as the holder intends to keep renewing, its useful life is indefinite.
2. Finite useful life
Amortized over the useful life, same conceptual logic as PPE depreciation, the enterprise expects to consume the asset's benefits over that time. What makes this harder than PPE: intangibles are usually knowledge/intellectual-property-based, so assessing useful life is more subjective.
The "lesser of legal life and economic life" rule: for intangibles with a legally-specified life (patents 20 years, copyrights = life of author + 50 years, industrial designs 10 years), the useful life for amortization purposes is at most the legal life, but could be shorter. Two contrasting worked examples straight from your text:
- A patent gives 20 years of legal protection for a medication, but competing superior products are expected in 10 years → useful life = 10 years (the shorter, economic constraint binds).
- The same medication is such a breakthrough that no competing product is expected even 30 years out → useful life = 20 years (the legal life binds, since it's shorter than the 30-year economic horizon).
- Similarly: copyright protects software for decades, but rapid software-development cycles mean the economic life is typically just a few years → useful life = the (much shorter) economic life.
Factors relevant to assessing useful life (beyond legal protection): speed of technical innovation/obsolescence, the market for related products, the useful life of any other asset the intangible depends on, competitive pressure, industry trends and stability.
The three parameters of amortization, useful life, amortizable amount (cost less residual value), and pattern of amortization, useful life is the one requiring the most judgment. IFRS presumes residual value is zero and that straight-line reflects the consumption pattern, unless there's specific evidence otherwise. In practice, nearly all firms use straight-line amortization with zero residual value.
Exhibit 9-5: Canadian Tire's actual amortization policy (from Note 3, 2022 financial statements)
"Intangible assets with indefinite useful lives are measured at cost, less any accumulated impairment and are not amortized. Intangible assets with finite useful lives are measured at cost and are amortized on a straight-line basis over their estimated useful lives, generally for a period of two to ten years."
Notice how this maps directly onto the concepts above: indefinite-life assets → cost less impairment, no amortization; finite-life assets → straight-line, with Canadian Tire's specific useful-life range (2–10 years) disclosed as required.
CheckpointCP9-3: What's the key question to ask before amortizing an intangible asset?
[!warning] Exam trap: "indefinite life" does NOT mean infinite life [CPA exam addition] The trap: treating indefinite-life intangibles as assets that last forever, or forgetting the second half of the consequence.
Why students miss it: the words are near-identical in ordinary usage.
Indefinite means there is no foreseeable limit to the period over which the asset is expected to generate net cash inflows. It does not mean infinite, and it does not mean permanent.
Two consequences, and you need both:
| # | Consequence |
|---|---|
| 1 | Do not amortize |
| 2 | Test for impairment annually, regardless of whether any indication exists |
The classification is also reassessed each period and can change to finite if circumstances change, at which point amortization begins prospectively.
Why the annual test is mandatory: unlike finite-life assets, there is no gradual amortization eroding the carrying value, so nothing catches an overvaluation before it becomes large and stale. The mechanics live in Chapter 10, including the rule that goodwill impairment can never be reversed.
Marker expectation: define indefinite correctly and state both consequences. Saying only "no amortization" is half an answer.
Caveat: technical-risk area identified from the structure of the standards, an asymmetry, exception, or look-alike concept. Not verified CPA Common Final Examination marker data.
A: Whether the asset has a finite or indefinite life, indefinite-life intangibles are never amortized.
Part C: Intangible Assets: Derecognition
Short section, derecognition works identically to PPE. Remove both the cost and accumulated amortization from the books; the difference between proceeds received and carrying amount is a gain or loss through profit or loss.
Part D: Goodwill
(LO 9-1, continued)
Although goodwill is intangible, it is treated as an asset separate from "intangible assets" in accounting, because it fails the identifiability test from Part 0's three-condition definition. Accounting goodwill = purchase price of a business − fair value of identifiable net assets (assets minus liabilities). Conceptually: how much extra is the buyer willing to pay for the business as a functioning whole, above and beyond the sum of its individually identifiable parts?
Real-world scale check: Canadian Tire's 2018 purchase of Teodin Holdco AS (owner of the Helly Hansen brand): total purchase price $766.3 million, of which only $331.4 million (43%) was identifiable assets/liabilities, while $434.9 million (57%) was goodwill. Goodwill was the majority of the purchase price, a vivid illustration that "the brand and the team and the customer relationships and the future growth story" can be worth more than everything you could otherwise put a specific label on.
Like indefinite-life intangibles, goodwill is never amortized, only tested for impairment.
Exhibit 9-6: Powell Company's purchase of Sooke Ltd. (full worked example)
Powell Company pays $60 million for Sooke Ltd. Powell's own analysis of Sooke's balance sheet produces these carrying-value vs. fair-value estimates:
| ($000s) | Carrying value | Fair value |
|---|---|---|
| Cash | 5,000 | 5,000 |
| Accounts receivable | 20,000 | 19,500 |
| Inventories | 15,000 | 14,000 |
| Property, plant, and equipment | 50,000 | 45,000 |
| Intangible assets (patents) | 1 | 9,500 |
| Total assets | 90,001 | 93,000 |
| Total liabilities | (50,000) | (50,000) |
| Net assets | 40,001 | 43,000 |
| Purchase price | 60,000 | |
| Goodwill (Purchase price − Fair value of net assets) | 17,000 |
Why fair value differs from carrying value, line by line (straight from your text): - Accounts receivable, fair value is lower because of uncollectible accounts, and because the carrying (book) balance doesn't reflect the time value of money (a dollar collectible in a year is worth less than a dollar today). - Inventories, fair value lower due to obsolescence. - PPE, fair value below carrying amount because accounting depreciation (systematic, historical-cost-based) has been less than the actual decline in fair value. - Intangible assets (patents), fair value ($9,500) vastly exceeds the nominal carrying value ($1!), because Sooke's own past R&D spending never satisfied the strict internal-development capitalization criteria from Part A, so almost none of the patents' true value ever hit Sooke's own balance sheet. Once Powell buys the whole company, though, that value gets recognized, via the acquisition, not via Sooke's own R&D efforts.
The arithmetic: fair value of assets $93M − fair value of liabilities $50M = net assets $43M. Powell paid $60M, so the $17M premium is goodwill.
Watch outExam trap: goodwill is NOT an intangible asset [CPA exam addition]
The trap: classifying goodwill as an intangible asset on the balance sheet or in a written answer.
Why students miss it: goodwill has no physical substance, is non-monetary, and sits immediately beside intangibles on the face of the statements. Two of the three defining conditions are satisfied, so everything looks right.
It fails the third condition, identifiability. An intangible asset must be either:
| Identifiability test | Goodwill? |
|---|---|
| Separable, capable of being sold, transferred, licensed, or exchanged on its own | No. It cannot be detached from the business |
| Arises from contractual or legal rights | No |
Goodwill is a residual plug: purchase price less the fair value of identifiable net assets acquired. Nobody measures it directly, it is whatever remains after allocating the price to everything that could be identified. That is precisely why it fails identifiability. Present it separately from intangible assets.
Marker expectation: state the identifiability test and say goodwill fails it. Classifying goodwill as an intangible asset is a definitional error, not a presentation preference.
Caveat: technical-risk area identified from the structure of the standards, an asymmetry, exception, or look-alike concept. Not verified CPA Common Final Examination marker data.
Critical conceptual point: goodwill is not an individually identifiable asset, it's simply "whatever's left over" once you've fair-valued everything else you can specifically identify. This is exactly why it fails the identifiability test and doesn't count as an "intangible asset" in the technical accounting sense, even though it's obviously not tangible either.
CheckpointCP9-4: Why is goodwill not an intangible asset for accounting purposes?
A: Because it isn't separately identifiable, one of the three defining characteristics of an intangible asset. Accounting goodwill is instead defined as the excess of a business's purchase price over the fair value of its identifiable net assets.
Part E: Presentation and Disclosure
(this week's core reading)
For intangible assets: group disclosures by class (similar nature/use), e.g., patents, copyrights, computer software, licences, industrial designs. Separately identify internally developed vs. acquired intangibles (since their accounting treatment differs so much, per Part A). For each class: disclose whether useful life is indefinite or finite; if indefinite, disclose why; if finite, disclose the amortization policy (useful life/rate and pattern), carrying amount, accumulated amortization, and where amortization hits the statement of comprehensive income. R&D costs expensed through profit or loss must be disclosed as their own amount. Finally, reconcile beginning-to-ending balances for each class (acquisitions, internal development, amortization, other changes).
For goodwill: disclosure is simpler, because goodwill is always treated as having an indefinite life, no amortization, so no amortization-related disclosure. Still requires a beginning-to-ending reconciliation, similar to intangible assets. (Impairments/revaluations of either goodwill or intangibles are covered in Chapter 10.)
Exhibit 9-7: Airbus's 2022 disclosures (real example)
Note 4, Significant Accounting Policies (R&D expenses): (quoted above in Part A, internally generated research expensed; internally generated development capitalized subject to Airbus's four listed conditions). Additional detail: "Capitalised development costs are recognised either as intangible assets or, when the related development activities lead to the construction of specialised tooling for production ('jigs and tools'), or involve the design, construction and testing of prototypes and models, as property, plant and equipment. Capitalised development costs are generally amortised over the estimated number of units produced. If the number of units produced cannot be estimated reliably, they are amortised over the estimated useful life of the internally generated intangible asset. Amortisation of capitalised development costs is recognised in cost of sales."
(Notice: Airbus sometimes amortizes based on units produced rather than straight-line time, a departure from the "nearly all firms use straight-line" norm mentioned in Part B, which makes sense for aerospace tooling tied directly to production volume.)
Note 20, Intangible Assets (reconciliation table, in € millions):
| Balance, Jan 1, 2022 | Exchange differences | Additions | Changes in consolidation scope | Reclassification | Disposals | Amortisation/Impairment | Balance, Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|
| Goodwill | 13,028 | 10 | 0 | 127 | 0 | 0 | 0 | 13,165 |
| Capitalised development costs | 1,286 | (12) | 319 | 0 | (1) | 0 | (110) | 1,482 |
| Other intangible assets | 2,053 | 89 | 160 | 159 | 5 | (7) | (338) | 2,121 |
| Total | 16,367 | 87 | 479 | 286 | 4 | (7) | (448) | 16,768 |
Notice how this exhibit demonstrates several Part D/E concepts at once: goodwill has zero amortization/impairment in the "Amortisation/Impairment" column ($0), confirming it's never amortized; the "Capitalised development costs" and "Other intangible assets" rows do show negative amounts there (impairment/amortization), consistent with being finite-life assets. Context from the chapter-opening vignette: Airbus's total intangibles + goodwill (€16.8 billion, essentially this table's €16,768M/€16.8B ending balance) was of a similar magnitude to its €16.5 billion in PP&E, a striking reminder that for a modern aerospace/defence manufacturer, intangible value can rival tangible value.
Part F: Mineral Resources
Common errorGAP (Flagged: covered in a previous week, per your Week 11 checklist) not this week's assigned material.
Included below since you uploaded the relevant images and have a standing preference for extra exposure. LO 9-3.
IFRS 6 governs accounting for costs of exploring for and evaluating mineral resources, the search for minerals, oil, natural gas, and similar non-regenerative resources (after obtaining legal exploration rights in an area), plus determining technical feasibility/commercial viability of extraction. Mining activity has three phases: exploration, development, extraction.
1. The three phases
Exploration is conceptually similar to the research phase of R&D, gathering knowledge about geology and mineral potential, with major uncertainty about both existence and commercial extractability. Unlike pure research (which IAS 38 requires to be expensed, no exceptions), IFRS 6 gives enterprises a choice: expense all exploration costs (same outcome as IAS 38), or capitalize them.
Once a project is established as technically feasible and commercially viable, it enters development, at this point, ordinary IAS 38 intangible-asset guidance applies. If a site turns out not worth further exploration/development, costs to that point are written off as impaired (Chapter 10). This is called the successful efforts method, only costs on exploration efforts that are ultimately successful remain capitalized by the end of the exploration phase.
Once the site is ready for extraction, it enters the extraction phase, where ordinary expense-recognition-matches-revenue-recognition rules apply.
Exhibit 9-8: Standards applicable across the three phases
┌─────────────────────────┬───────────────────────┬──────────────────────┐
│ Exploration & evaluation │ Development phase │ Extraction phase │
│ phase │ │ │
│ Determination of │ Preparation of mine │ Site is ready for │
│ technical feasibility │ site and installation │ resource mineral │
│ and commercial viability │ of equipment for the │ production │
│ of project site │ purpose of resource │ │
│ │ extraction │ │
├─────────────────────────┼───────────────────────┼──────────────────────┤
│ IFRS 6 │▲ IAS 38 │ Expense │
└─────────────────────────┴┼───────────────────────┴──────────────────────┘
│
Determine success or failure of exploration;
evaluate impairment using IAS 36.
In briefTHRESHOLD: Conceptual Framework
Why does IFRS allow choice for mineral exploration capitalization, but require research costs to always be expensed, when both are conceptually similar knowledge-discovery activities? The answer is the degree of uncertainty. There are deep, liquid commodity markets for gold, copper, uranium, oil, and gas, a discovered mineral deposit can be sold at some price with reasonable confidence. There is no comparable market for "a research idea", no guarantee it can be sold at any price at all. For the same reason, once a mineral site reaches the development phase, it would normally satisfy the capitalization criteria for development costs (the same IAS 38 ¶57 criteria referenced in Part A).
2. The full cost alternative (ASPE only)
Full cost method: capitalize all mineral exploration costs, regardless of whether any specific project succeeds or fails. ASPE permits a choice between full cost and successful efforts (this choice was also available to Canadian public companies before mandatory IFRS adoption on January 1, 2011).
In briefTHRESHOLD: Conceptual Framework
The two methods reflect genuinely different readings of the "probable future benefit" asset-definition criterion. Successful efforts: costs on a site that never produces have no future benefit, expense them; costs on successful sites do have future benefit, capitalize them. Full cost: exploration is inherently risky as a whole portfolio, some sites succeed, some don't, but the costs across all sites are part of one unified process of "discovering productive sites and generating future revenue," so all exploration costs have expected future benefit from that broader, portfolio-level perspective, even though some specific sites will, after the fact, turn out unproductive.
Exhibit 9-9: Real-world policy excerpts
BP plc (successful efforts, 2022 annual report, USD $288 billion in assets): exploration licence/leasehold acquisition costs are capitalized as intangible assets, reviewed each period for impairment indicators (is drilling still underway/planned? has commercial viability been determined or is work underway to determine it?), if no future activity is planned, the remaining balance is written off; lower-value licences are pooled and amortized straight-line over the estimated exploration period. Geological/geophysical exploration costs are expensed as incurred; costs directly tied to a specific exploration well are capitalized as an intangible asset until drilling is complete and results evaluated, written off if no commercial hydrocarbons found, kept as an asset if they are (subject to further appraisal). Upon internal approval for development, costs move from intangible assets to PPE.
Ovintiv, formerly Encana Corporation (full cost, 2022 annual report, prepared under US GAAP): "Ovintiv uses the full cost method of accounting for its acquisition, exploration, and development activities. Accordingly, all costs directly associated with the acquisition of, the exploration for, and the development of oil, NGLs [natural gas liquids], and natural gas reserves, including costs of undeveloped leaseholds, dry holes, and related equipment, are capitalized on a country-by-country cost centre basis... Capitalized costs accumulated within each cost centre are depleted using the unit-of-production method based on proved reserves.", notice "dry holes" (unsuccessful wells) are explicitly capitalized here, the defining feature that distinguishes full cost from successful efforts.
CheckpointCP9-5: Why does IFRS permit capitalizing exploration costs but not research costs?
A: Different degrees of uncertainty. Both aim to discover new knowledge, but there's much less uncertainty about the value of knowledge regarding commercially viable mineral quantities (well-developed commodity markets exist) than about the value of a research finding (no developed market for research ideas).
3. Other aspects
After initial recording, enterprises can apply either the cost model or the revaluation model (Chapter 10) to capitalized mineral exploration costs, and must evaluate for impairment like other long-lived assets. Depletion of these costs normally uses the units-of-production method.
4. Worked example: Peace River Exploration Co. (PREC)
20X1 exploration costs by well:
| Well | Costs incurred | Status at year-end |
|---|---|---|
| A | $400,000 | Producing |
| B | $600,000 | Abandoned |
| C | $300,000 | Abandoned |
| D | $500,000 | In development |
| E | $200,000 | Exploration/evaluation ongoing |
Additional development-phase PPE costs: $800,000 (Well A) + $500,000 (Well D) = $1,300,000. During the year, Well A produced 20,000 barrels out of an estimated 500,000-barrel reserve (i.e., 4% of reserves extracted).
Exhibit 9-10: PREC's accounting under both methods
Recording exploration costs:
| Successful efforts method | Full cost method | ||
|---|---|---|---|
| Dr. Exploration expenses: Well B | 600,000 | ||
| Dr. Exploration expenses: Well C | 300,000 | ||
| Dr. Intangible assets: Well A | 400,000 | ||
| Dr. Intangible assets: Well D | 500,000 | ||
| Dr. Intangible assets: Well E | 200,000 | Dr. Intangible assets, exploration | 2,000,000 |
| Cr. Cash | 2,000,000 | Cr. Cash | 2,000,000 |
(Both methods pay out the same total $2,000,000 cash, the difference is entirely in how much gets expensed [$900,000: Wells B+C, successful efforts only] vs. capitalized [$1,100,000 successful efforts / all $2,000,000 full cost].)
Recording development costs (identical under both methods):
| Dr. PPE: Well A: 800,000 |
|---|
| Dr. PPE: Well D: 500,000 |
| Cr. Cash: 1,300,000 |
Recording depletion and depreciation:
| Successful efforts method | Full cost method | ||
|---|---|---|---|
| Dr. Depletion expense | 16,000 | Dr. Depletion expense | 80,000 |
| Cr. Accum. depletion: Well A ($400,000 × 4%) | 16,000 | Cr. Accum. depletion ($2,000,000 × 4%) | 80,000 |
| Dr. Depreciation expense | 32,000 | Dr. Depreciation expense | 32,000 |
| Cr. Accum. depreciation: Well A ($800,000 × 4%) | 32,000 | Cr. Accum. depreciation: Well A ($800,000 × 4%) | 32,000 |
Why depletion differs but depreciation doesn't: successful efforts only has Well A's $400,000 capitalized as an intangible asset (Wells B and C were expensed outright; D and E aren't producing yet), so depletion = $400,000 × 4% = $16,000. Full cost has all $2,000,000 of exploration cost capitalized regardless of well-by-well success, so depletion = $2,000,000 × 4% = $80,000, five times larger. Depreciation is identical ($32,000) under both methods, because development-phase PPE costs ($800,000 for Well A) are capitalized the same way regardless of which exploration-cost method is used, the two methods only disagree about exploration-phase costs, not development-phase costs.
Part G: Government Grants
Common errorGAP (Flagged: covered in a previous week, per your Week 11 checklist) not this week's assigned material.
Included below for the same reason as Part F. LO 9-4.
Governments provide assistance for many reasons: federal investment tax credits for equipment/facilities (economic stimulus), provincial rebates for emissions-reducing equipment, municipal property tax concessions for low-cost housing. The core questions IAS 20 answers: should the grant go through equity directly, or through income? When should it be recognized? Gross or net presentation?
Running example: Ocean Falls Company: the federal government provides a 4-year, $20,000,000 forgivable loan to acquire a Canadian production facility; $5,000,000 is forgiven for each year the company employs at least 500 people in Canada. The facility costs $100,000,000 with a 20-year useful life.
1. Equity (capital) approach vs. income approach
Capital approach: grants aren't part of the earning process, so they shouldn't be revenue/expense-reductions, credit equity directly. Income approach: grants are earned, because conditions must be satisfied to receive them, so they're appropriately part of income.
IFRS requires the income approach. IAS 20 ¶12: "Government grants shall be recognized in profit or loss on a systematic basis over the periods in which the entity recognizes as expenses the related costs for which the grants are intended to compensate."
TrapTHRESHOLD: Quality of Earnings / Conceptual Framework
Normally, accrual accounting matches expenses to revenue, never the reverse (matching both ways would be circular, with no external anchor, any number would look "as good as" any other). Government grants are a deliberate exception: match income (the grant) to expenses/costs. This doesn't create circularity because the grant is secondary to ordinary operating revenue, you apply revenue recognition first, match expenses to that revenue as usual, and only then match the grant income to the related expenses. For grants tied to acquiring an asset like PPE, the "related cost" is the depreciation of that asset, so the grant's income effect is recognized over the same period as the PPE's depreciation, not all at once.
For Ocean Falls specifically: since the loan is for acquiring production facilities, its benefit should be recognized over the facility's useful life, not all at once when the cash is received.
2. Timing of recognition
Enterprises record grants only when reasonably assured they've complied (or will comply) with the conditions and that the grant will actually be received. If Ocean Falls intends to maintain ≥500 employees for the full 4 years, it can recognize the full $20,000,000 upfront (rather than building it up $5,000,000 at a time as each year's condition is met).
Exhibit 9-11: Initial journal entry for Ocean Falls' grant receipt
Dr. Cash 20,000,000
Cr. Deferred income (a liability) or PPE* 20,000,000
(Whether "Deferred income" or a direct credit to "PPE" is used depends on the gross vs. net method, see below.)
Exhibit 9-12: Recognizing income on the grant
Since the facility is depreciated over 20 years, the $20,000,000 grant produces $1,000,000 of income per year for 20 years:
Dr. Deferred income 1,000,000
Cr. Other income (government grant) 1,000,000
— OR, no separate entry at all if the grant was initially credited directly against PPE.
3. Gross vs. net presentation
Gross method: shows the grant as separate line items on the balance sheet and income statement. Net method: offsets the grant directly against the related financial statement item (the asset, or the expense).
Exhibit 9-13: Accounts affected under each method
Watch outExam trap: gross vs. net grant presentation does NOT change profit [CPA exam addition]
The trap: asserting that one presentation improves reported profit or net assets.
Why students miss it: two presentations that look this different feel like they must produce different results. They do not.
Under IAS 20, gross and net presentation produce IDENTICAL net income and IDENTICAL net assets. What changes is presentation-based ratios, and materially so.
| Gross method | Net method | |
|---|---|---|
| Asset carrying amount | Full cost | Cost less the grant |
| Deferred grant liability | Recognized | Not recognized |
| Net income | Identical | Identical |
| Net assets | Identical | Identical |
| Leverage ratio (source figure) | $19 \div 95 = \mathbf{20\%}$ | 0% |
Same economics, materially different-looking balance sheet. A firm approaching a debt covenant has an obvious reason to prefer net presentation, which is exactly why this is examinable.
Marker expectation: state explicitly that net income and net assets are unchanged, then identify which ratios are distorted and why. Claiming a profit difference is simply wrong.
Caveat: technical-risk area identified from the structure of the standards, an asymmetry, exception, or look-alike concept. Not verified CPA Common Final Examination marker data.
| Gross method | Net method | |
|---|---|---|
| Grants related to income, recognition matching related costs | Dr. Cash / Cr. Other income (government grant) | Dr. Cash / Cr. Related expense |
| Grants related to assets, initial recognition | Dr. Cash / Cr. Deferred income | Dr. Cash / Cr. PPE or other relevant asset |
| Grants related to assets, subsequent periods | Dr. Deferred income / Cr. Other income (government grant) | No specific entries; income recognized through reduced depreciation |
Exhibit 9-14: Ocean Falls, gross vs. net, full journal entries ($ millions)
| Gross method | Net method | |
|---|---|---|
| Initial: PPE purchase | Dr. PPE 100 / Cr. Cash 100 | Dr. PPE 100 / Cr. Cash 100 |
| Initial: grant receipt | Dr. Cash 20 / Cr. Deferred income 20 | Dr. Cash 20 / Cr. PPE 20 |
| Subsequent: grant income | Dr. Deferred income 1 / Cr. Other income 1 | No entry, reflected via lower depreciation |
| Subsequent: depreciation | Dr. Depreciation expense 5 / Cr. Accum. dep. 5 | Dr. Depreciation expense 4 / Cr. Accum. dep. 4 |
The bottom-line effect on comprehensive income is identical either way: $4 million per year net (gross method: $5M depreciation expense − $1M grant income = $4M net cost; net method: $4M depreciation expense directly, since it's based on the already-reduced $80M PPE cost basis). Only the presentation differs, gross shows the two flows separately; net shows them pre-combined.
Exhibit 9-15: Balance sheet impact over the full 20 years ($ millions)
| End of year | Gross: PPE | Gross: Accum. dep.* | Gross: Net PPE | Gross: Deferred income (liability)† | Gross: Net PPE less deferred income | Net: PPE | Net: Accum. dep.‡ | Net: Net PPE |
|---|---|---|---|---|---|---|---|---|
| 0 | 100 | — | 100 | (20) | 80 | 80 | 0 | 80 |
| 1 | 100 | (5) | 95 | (19) | 76 | 80 | (4) | 76 |
| 2 | 100 | (10) | 90 | (18) | 72 | 80 | (8) | 72 |
| 3 | 100 | (15) | 85 | (17) | 68 | 80 | (12) | 68 |
| ⋮ | ||||||||
| 18 | 100 | (90) | 10 | (2) | 8 | 80 | (72) | 8 |
| 19 | 100 | (95) | 5 | (1) | 4 | 80 | (76) | 4 |
| 20 | 100 | (100) | 0 | (0) | 0 | 80 | (80) | 0 |
*Straight-line: $100M ÷ 20 years = $5M/year. †Straight-line: $20M ÷ 20 years = $1M/year. ‡Straight-line: $80M ÷ 20 years = $4M/year.
The two methods converge to the exact same "net PPE" figure every single year, this is the same articulation logic you've seen throughout your course: different presentations of the same underlying economics must reconcile.
Exhibit 9-16: Why does IFRS allow both? (Neither is "more correct")
| Issue | Gross method's argument | Net method's argument |
|---|---|---|
| Should financial statement items be offset? (IAS 1 ¶32: generally no, unless integrally related) | A government grant is distinct from the cost incurrence itself, so don't offset them | The enterprise acquires the asset/incurs the expense with full knowledge of (and expectation of) the grant's cost reduction, so they are integrally related |
| What is "the cost" of the asset/expense? | The actual purchase price/construction cost is the cost, full stop | In competitive markets, subsidized items have higher underlying prices that partly/fully offset the subsidy, so the "true" cost must include the grant's effect |
A practical reason enterprises tend to prefer net presentation: it produces lower liabilities and better (lower) leverage ratios. Using Ocean Falls (assuming no other assets/liabilities): gross method debt-to-assets = 19 ÷ 95 = 20% at the end of Year 1; net method = 0%. Same underlying economics, very different-looking balance sheet ratios, a good reminder to always check which presentation method a company you're analyzing has chosen before comparing leverage ratios across companies.
CheckpointCP9-6: How should enterprises report government grants?
A: (i) Using the income approach; (ii) once reasonably assured of satisfying the grant's conditions; (iii) using either the gross or net presentation method.
Repayable grants: if circumstances change and a grant becomes repayable, IFRS and ASPE diverge (see Part I below).
Part H: Potential Earnings Management
TrapTHRESHOLD: Quality of Earnings
Intangibles, mineral resources, and government grants all involve heavy professional judgment with long-lasting consequences, creating real incentives and opportunities for earnings management.
1. Capitalization of development costs
The six criteria are deliberately strict to prevent over-capitalization, but that same strictness makes under-capitalization easy: a company only needs to show it fails any one of the six criteria to justify expensing (understating both earnings and assets, the opposite bias from over-capitalization). A subtler trick: suddenly starting to capitalize development costs in one year, after years of not doing so, even when the criteria could have been met all along, can manufacture the appearance of improved performance.
2. Estimated useful lives of intangible assets
Useful-life bias is a known issue for PPE (previous chapter), it's even worse for intangibles, given how uniquely uncertain their economic lives are (how do you really estimate "the speed of technological advancement"?). This is less of a concern for internally developed intangibles (the strict capitalization criteria already limit what gets capitalized in the first place) but very significant for acquired intangibles, where large amounts get capitalized with a management-chosen useful life.
3. Determination of exploration success or failure
Under the successful efforts method, costs sit capitalized temporarily until success/failure is determined. The timing of that determination is discretionary, delaying the conclusion that a site is a failure defers the exploration expense from one fiscal year into the next, exactly the kind of "smoothing" earnings management you should be alert to.
Part I: Substantive Differences: IFRS vs. ASPE
| Issue | IFRS | ASPE |
|---|---|---|
| Mineral exploration costs | Only permits successful efforts; unsuccessful exploration costs are expensed via the impairment test | Permits either successful efforts or full cost (full cost allows capitalizing all extraction-phase costs) |
| Repayment of government grants | Treated as a change in estimate, but with a ==cumulative catch-up adjustment== for additional past depreciation | Treated ==prospectively (no catch-up adjustment)== |
Why this matters: the government-grants row is a nice callback to Chapter 3's error/policy-change/estimate-change framework, repayment of a grant is explicitly classified as a change in estimate under IFRS (meaning: catch up the balance sheet now, but don't restate prior years), whereas ASPE just changes the future treatment prospectively with no catch-up at all, a genuinely different mechanical result, not just a labelling difference.
Part J: Summary by Learning Objective
LO 9-1: Evaluate whether a cost qualifies for capitalization as an intangible asset or goodwill: enterprises capitalize acquired intangible assets and goodwill from a business purchase; internally developed intangible costs are expensed unless they're development costs satisfying six criteria (future benefits, ability/intention to exploit them, reliable cost measurement).
LO 9-2: Evaluate indefinite vs. finite life, and determine useful life if finite: an intangible has an indefinite life if the enterprise expects benefits to continue at a similar level for the foreseeable future (not amortized); finite-life intangibles are amortized over estimated useful life, generally assuming nil residual value and straight-line method absent contrary evidence.
LO 9-3: Apply specialized standards for mineral resource exploration/evaluation: IFRS requires the successful efforts method; ASPE allows a choice between successful efforts and full cost. Successful efforts capitalizes only costs on projects with technically feasible, commercially viable discoveries; full cost capitalizes everything regardless of success/failure. Development costs are generally capitalized under both.
LO 9-4: Apply standards for government grants: enterprises reasonably assured of receiving a grant recognize its fair value through profit or loss over the periods matching the related costs, using either gross or net presentation.
Part K: Checkpoint Questions and Answers
Common errorGAP
Per your source file's own end note, CP9-1 and CP9-2's original question wording is missing, only the answers survived extraction. The questions below are my inference from the answer content, clearly marked as such, not verbatim quotes.
CP9-1: Q (inferred, not verbatim): What are the three characteristics that define an intangible asset, and what does each one rule out? A (verbatim from your source): The three characteristics of an intangible asset are its lack of physical substance, non-monetary nature, and identifiability. Lack of physical substance separates intangible assets from tangible assets such as inventories. Non-monetary nature separates intangible assets from financial assets. Identifiability separates intangible assets from goodwill.
CP9-2: Q (inferred, not verbatim): Why do acquired and internally developed intangibles receive such different accounting treatment? A (verbatim from your source): The key reason for the difference in treatment is the degree of subjectivity in measuring the future benefits of intangibles. For acquired intangibles, we can presume that the purchase price is a valid reflection of management's expectations of future benefits, so the purchase cost can be capitalized. In contrast, the costs incurred in developing intangibles internally do not closely correspond to expected future benefits, so strict criteria are required to limit the degree of management discretion in the capitalization of research and development costs.
✅ CP9-3: Q: What's the key question to ask before amortizing an intangible asset? A: Whether it has a finite or indefinite life, indefinite-life intangibles are never amortized.
✅ CP9-4: Q: Why is goodwill not an intangible asset for accounting purposes? A: It's not separately identifiable. Accounting goodwill is the excess of a business's purchase price over the fair value of its identifiable assets.
✅ CP9-5: Q: Why does IFRS permit capitalizing exploration costs but not research costs? A: Different degrees of uncertainty, developed commodity markets exist for minerals, but no developed market exists for research ideas.
✅ CP9-6: Q: How should enterprises report government grants? A: Using the income approach, once reasonably assured of meeting the grant's conditions, presented using either the gross or net method.
Part L: References
| IFRS | ASPE |
|---|---|
| IAS 38: Intangible Assets | Section 3064: Goodwill and Intangible Assets |
| IFRS 3: Business Combinations | Section 1582: Business Combinations |
| IFRS 6: Exploration for and Evaluation of Mineral Resources | AcG 16: Oil and Gas Accounting: Full Cost |
| IAS 20: Accounting for Government Grants and Disclosure of Government Assistance | Section 3800: Government Assistance |
(AcG = Accounting Guideline.)
Additional Practice (supplementary, not from your textbook)
These two problems are my own construction, built because you asked for more practice and exposure, clearly not textbook quotes or exhibits.
Practice Problem 1: Goodwill calculation drill
Nelson Corp. purchases Kaslo Ltd. for $35 million. Kaslo's balance sheet and Nelson's fair value assessment:
| ($000s) | Carrying value | Fair value |
|---|---|---|
| Cash | 2,000 | 2,000 |
| Accounts receivable | 8,000 | 7,600 |
| Inventories | 6,000 | 5,500 |
| PPE | 20,000 | 18,000 |
| Intangible assets | 0 | 4,000 |
| Total liabilities | (10,000) | (10,000) |
Work it through, then check below:
- Total assets (fair value): 2,000 + 7,600 + 5,500 + 18,000 + 4,000 = $37,100 thousand
- Net assets (fair value): $37,100 − $10,000 = $27,100 thousand ($27.1 million)
- Goodwill = Purchase price − fair value of net assets = $35,000 − $27,100 = $7,900 thousand ($7.9 million)
- (Note the same pattern as Sooke Ltd.: intangible assets carried at $0 on Kaslo's own books but fair-valued at $4,000, almost certainly because Kaslo's own R&D never met the internal-development capitalization criteria, exactly like the Sooke Ltd. example above.)
Practice Problem 2: Finite vs. indefinite life classification drill
For each intangible asset below, decide finite or indefinite life, and if finite, what governs the useful life estimate. Try each one before checking the answer.
- A perpetually renewable broadcast licence, which the company has always renewed and intends to keep renewing. → Indefinite, same logic as the trademark example: renewable without limit, and management intends to keep renewing, so benefits are expected to continue for the foreseeable future. Tested for impairment annually, never amortized.
- A patent on a drug, with 20 years of legal life remaining, but a competing drug is expected to make it obsolete in 7 years. → Finite, useful life = 7 years, the lesser of legal life (20 years) and economic life (7 years) governs, exactly as in the medication example in Part B.
- A customer list acquired in a business purchase, expected to generate benefits for roughly 5 years before customer turnover erodes its value. → Finite, useful life ≈ 5 years, no legal-life ceiling here at all (customer lists aren't legally registered like patents/trademarks), so the estimate rests entirely on the economic/behavioural assumption (customer turnover), which is inherently more judgment-heavy, precisely the earnings-management risk flagged in Part H.
Executive Summary (One Page)
This chapter extends the three-stage asset framework (initial recognition, subsequent measurement, derecognition) from the previous PPE chapter to assets that lack physical substance, and spends most of its effort on the first stage, because that's where intangibles pose genuinely new questions. An intangible asset must satisfy three conditions simultaneously: no physical substance, non-monetary, and identifiable, the last condition being what separates a true intangible asset from goodwill, which can never be sold on its own and only exists as a residual "premium" paid for a business as a whole.
The central recognition question the chapter returns to repeatedly is why acquired intangibles (capitalized at their market-validated purchase price) and internally developed intangibles (mostly expensed, unless strict development-cost criteria are met) receive such different treatment: an external transaction price is objective evidence of expected future benefit, while self-generated costs are not, and management has an obvious incentive to overstate future benefits if left with full discretion, hence research-phase costs are always expensed, development-phase costs are capitalized only once specific criteria are demonstrated, and post-development costs are expensed again, mirroring the same "ready for intended use" cutoff you saw for PPE.
Subsequent measurement hinges on one judgment call: does the asset have an indefinite life (tested annually for impairment, never amortized) or a finite one (amortized straight-line, generally assuming zero residual value, over the lesser of its legal and economic life)? Goodwill gets its own extended treatment because, despite never being amortized (like an indefinite-life intangible), it is calculated very differently, as the plug figure left over once a purchase price is compared against the fair value of everything specifically identifiable, a calculation made vivid by the Powell/Sooke Ltd. example where patents carried at a nominal $1 on the target's own books were fair-valued at $9.5 million once acquired, precisely because the target's own R&D spending never cleared the capitalization bar.
Two further specialized topics close out the chapter, both flagged in this guide as content your syllabus scheduled for an earlier week rather than this one: mineral resource exploration, where IFRS mandates the "successful efforts" method (capitalize only costs on ultimately successful sites, expense the rest) while ASPE also permits the more permissive "full cost" method (capitalize everything, successful or not), a divergence justified by different readings of how "probable future benefit" applies when a portfolio of exploration sites includes both successes and failures; and government grants, where IFRS requires the income approach (matching grant income to the related expense it compensates for, a deliberate and narrow exception to accrual accounting's usual one-directional expense-to-revenue matching), recognized once an enterprise is reasonably assured of meeting the grant's conditions, and presentable on either a gross basis (grant shown as its own line item) or net basis (grant offset directly against the related asset or expense), two presentations that produce identical net income but meaningfully different-looking leverage ratios, which is worth remembering any time you compare two companies' balance sheets without checking which method each one uses. A recurring thread across every topic in this chapter is how much professional judgment is involved and how long-lasting the consequences are, which is exactly why the chapter closes with a dedicated look at how each of these judgment calls (development-cost capitalization, useful-life estimates, exploration success/failure timing) can be, and sometimes is, used to manage reported earnings.
Key Takeaways
- An intangible asset must be non-physical, non-monetary, AND identifiable, all three at once. Missing identifiability is exactly what makes goodwill different from an "intangible asset" in the technical accounting sense.
- Acquired intangibles are capitalized at their market-validated purchase price; internally developed intangibles are expensed by default, capitalized only if strict development-cost criteria are demonstrably met.
- Research-phase costs are always expensed; development-phase costs may be capitalized once criteria are met; post-development-phase costs are expensed again (the intangible is now "ready for use," mirroring PPE's cutoff logic).
- Indefinite-life intangibles (and goodwill) are never amortized, only tested for impairment annually. Finite-life intangibles are amortized over the lesser of legal life and economic life, generally straight-line with zero residual value.
- Goodwill = purchase price − fair value of identifiable net assets. It is a residual "plug," not a separately identifiable asset, and can be a very large fraction of a purchase price (57% in the real Canadian Tire/Helly Hansen example).
- IFRS requires the successful efforts method for mineral exploration; ASPE additionally permits the full cost method, which capitalizes exploration costs on both successful and unsuccessful sites alike.
- Government grants are recognized via the income approach (not credited straight to equity), once the enterprise is reasonably assured of meeting the grant's conditions, and matched to the same periods as the related expense (e.g., depreciation) they're intended to offset.
- Gross and net presentation of government grants produce identical net income effects but very different-looking balance sheets and leverage ratios, always check which method a company uses before comparing ratios across companies.
- Repayment of a government grant is a change in estimate (with a catch-up adjustment) under IFRS, but purely prospective under ASPE, a genuinely different mechanical outcome, not just a presentation difference.
- Nearly every judgment call in this chapter (development-cost capitalization, useful-life estimation, exploration success/failure timing) is a documented avenue for earnings management, know not just the rule, but the specific way each rule can be gamed.
Common Misconceptions and Mistakes
- Treating goodwill as just another intangible asset. It fails the identifiability test on purpose, it's a distinct category with its own (simpler) disclosure rules and its own (residual, plug-figure) measurement approach.
- Assuming "indefinite life" means "never has to be tested for anything." Indefinite-life intangibles and goodwill skip amortization, but they are not exempt from impairment testing, if anything, they require it every year, without exception.
- Assuming a patent's or copyright's legal life is automatically its useful life for amortization. Useful life is the lesser of legal life and economic life, a technologically obsolete patent can have a useful life far shorter than its remaining 20-year legal protection.
- Assuming internally developed intangibles are simply never capitalized. They can be, but only the development-phase costs, and only once specific criteria are demonstrably satisfied; research-phase and post-development-phase costs are expensed regardless.
- Assuming LIFO-style manipulation risk is unique to inventory (Chapter 6). This chapter shows the same underlying theme (management discretion + long time horizons = manipulation risk) shows up in totally different contexts: development-cost capitalization timing, useful-life estimates, and exploration success/failure timing.
- Assuming gross vs. net presentation of a government grant changes the "real" numbers. It doesn't, net income is identical either way; only where the numbers show up (separate line items vs. netted together) differs, which is exactly why it can distort ratio comparisons if you're not careful.
- Confusing "successful efforts" with "conservative" and "full cost" with "aggressive" as a blanket rule. That's the practical tendency, but the actual conceptual difference is about which future-benefits interpretation each method adopts (site-by-site vs. portfolio-wide), not simply which one reports lower numbers.
Cheat Sheet
The three-condition intangible asset test
No physical substance? AND Non-monetary? AND Identifiable?
↓ ALL THREE YES ↓ fails identifiability
Intangible asset Goodwill (only if arising
from a business purchase)
R&D capitalization phases
| Phase | Treatment |
|---|---|
| Research | Always expense |
| Development (if criteria met, six criteria per IAS 38 ¶57, not fully enumerated in your source) | Capitalize |
| Post-development (asset ready for use) | Expense (further costs are period costs) |
Amortization decision
| Indefinite life | Finite life | |
|---|---|---|
| Amortize? | No | Yes, over useful life |
| Instead, do what? | Test for impairment every year | Amortize (typically straight-line, nil residual value) |
| Useful life = | N/A | Lesser of legal life and economic life |
Goodwill formula
Goodwill = Purchase price − (Fair value of identifiable assets − Fair value of liabilities) Goodwill = Purchase price − Fair value of identifiable net assets
Mineral exploration methods
| Successful efforts (IFRS + ASPE) | Full cost (ASPE only) | |
|---|---|---|
| Capitalizes costs on... | Only successful sites | All sites, successful or not |
| Costs on failed sites | Expensed | Capitalized |
| View of "future benefit" | Site-by-site | Portfolio-wide |
Government grants
| Step | Rule |
|---|---|
| Approach | Income approach (not direct-to-equity): IAS 20 ¶12 |
| Timing | Once reasonably assured of meeting conditions |
| Matching | Income matched to the related expense (reverse of the usual expense-to-revenue direction) |
| Presentation | Gross (separate line items) or Net (offset against the asset/expense), same net income either way |
| Repayment (IFRS) | Change in estimate, with cumulative catch-up adjustment |
| Repayment (ASPE) | Prospective only, no catch-up |
Key terminology glossary
| Term | Definition |
|---|---|
| Intangible asset | Identifiable, non-monetary asset without physical substance |
| Goodwill | Purchase price of a business less the fair value of its identifiable net assets; not separately identifiable |
| Amortization | Systematic allocation of a finite-life intangible's cost to expense over its useful life (the "depreciation" of intangibles) |
| Indefinite useful life | Expected to generate benefits at a similar level for the foreseeable future, not amortized, tested for impairment annually |
| Successful efforts method | Capitalizes mineral exploration costs only on sites that prove successful |
| Full cost method | Capitalizes all mineral exploration costs regardless of success/failure (ASPE only) |
| Government grant | Government assistance recognized through profit or loss (income approach), matched to related expenses |
| Gross method (grants) | Grant shown as a separate line item (deferred income liability, other income) |
| Net method (grants) | Grant offset directly against the related asset or expense |
| Depletion | The natural-resource-industry version of amortization/depreciation, typically using the units-of-production method |
End of study guide.
Cross-Chapter Connections
- Chapter 8: Tangible assets. Chapter 9 is defined largely by contrast: intangibles lack physical substance, are non-monetary, and must be identifiable. The capitalization criteria mirror PPE's with "cost" replaced by a stricter demonstration test.
- Chapter 10: Impairment. Goodwill and indefinite-life intangibles are tested for impairment annually regardless of indications, the rule lives here but the mechanics live in Chapter 10. Note the carve-out: goodwill impairment can never be reversed.
- Chapter 3: Changes in estimate. IFRS treats government grant repayment as a change in estimate applied prospectively, in contrast to ASPE's catch-up approach.
- Chapter 2: Recognition criteria. The identifiability and control tests are the Framework's asset definition applied to non-physical resources.
- Chapter 1: Earnings management. Under-capitalization of development costs and useful-life bias are Chapter 1's discretion problem in a specific standard.
Common CPA Exam Traps
Watch outHigh-yield technical traps
Caveat: technical-risk areas identified from the structure of the standards, asymmetries, exceptions, look-alike concepts. Not verified CPA Common Final Examination marker data.
| # | Trap | Why students miss it | Correct approach | Marker expectation |
|---|---|---|---|---|
| 1 | Calling goodwill an intangible asset | It has no physical substance, it is non-monetary, and it sits near intangibles on the balance sheet. Everything looks right. | ==Goodwill fails the identifiability test.== An intangible asset must be separable (capable of being sold, transferred, licensed, or exchanged on its own) or arise from contractual/legal rights. Goodwill is neither, it cannot be separated from the business. It is a residual plug: purchase price less the fair value of identifiable net assets acquired. Present it separately from intangible assets. | State the identifiability test and say goodwill fails it. Classifying goodwill as an intangible asset is a definitional error, not a presentation preference. |
| 2 | Reading "indefinite life" as "infinite life" | The words are near-identical. | Indefinite means no foreseeable limit to the period over which the asset is expected to generate net cash inflows, not that it lasts forever. The accounting consequence is precise: ==do not amortize; test for impairment annually.== The classification is also reassessed each period and can change to finite. | Define indefinite correctly and state both consequences, no amortization and mandatory annual impairment testing. |
| 3 | Gross vs. net presentation of government grants changes profit | Two presentations that look so different feel like they must produce different results. | Under IAS 20, gross and net presentation produce identical net income and identical net assets. What changes is presentation-based ratios. Your source's own figure: a leverage ratio of $19 \div 95 = \mathbf{20\%}$ under gross presentation versus 0% under net, the same economics, a materially different-looking balance sheet. | Say explicitly that net income and net assets are unchanged, then identify which ratios are distorted. Claiming a profit difference is wrong. |
| 4 | Capitalizing development costs without demonstrating all six criteria | Development sounds inherently capitalizable. | All six IAS 38 ¶57 criteria must be demonstrated. Failing any one forces expensing. Research-phase costs are always expensed; post-development costs are period costs. | List the criteria you are relying on and address each. "Development costs are capitalized" without the demonstration scores nothing. |
| 5 | Using legal life instead of the shorter of legal and economic life | The legal life is a stated fact in the problem. | Amortize over the lesser of legal life and economic (useful) life. A 20-year patent on a technology obsolete in 6 years amortizes over 6. | State the rule and identify which life binds. |
| 6 | Mixing up successful efforts and full cost | Both are permitted policy choices under IFRS 6. | Successful efforts capitalizes only costs of successful exploration; unsuccessful costs are expensed. Full cost capitalizes all exploration costs within a cost centre. The choice materially affects both asset values and the timing of expense recognition, which is why it is an earnings-management lever. | Name the method, state what it does with unsuccessful costs, and note the earnings implication. |
Key IFRS/ASPE Rules
ImportantRules and citations
IAS 38 ¶57: the six development-cost capitalization criteria [Audit fix]
Your source references "the six criteria" at least three times but never lists them. All six, supplied per your instruction:
| # | Criterion |
|---|---|
| 1 | Technical feasibility of completing the intangible asset so that it will be available for use or sale |
| 2 | Intention to complete the asset and use or sell it |
| 3 | Ability to use or sell the asset |
| 4 | How the asset will generate probable future economic benefits, demonstrating a market for the output or the asset itself, or its usefulness if used internally |
| 5 | Availability of adequate technical, financial, and other resources to complete development and to use or sell the asset |
| 6 | Ability to reliably measure the expenditure attributable to the asset during its development |
All six must be demonstrated. Failing any one forces expensing.
[VERIFY: paragraph number and exact wording against the CPA Canada Handbook Part I before quoting verbatim. Criteria supplied per your explicit instruction; the paragraph reference has not been independently re-confirmed.]
Other rules
| Rule | Standard |
|---|---|
| Intangible asset requires: no physical substance, non-monetary, and identifiable | IAS 38 |
| Goodwill is not an intangible asset, it fails identifiability; presented separately | IFRS 3 |
| Indefinite-life intangibles and goodwill: do not amortize; test annually | IAS 38 / IAS 36 |
| Amortize finite-life intangibles over the lesser of legal and economic life | IAS 38 |
| Exploration and evaluation: policy choice of successful efforts or full cost | IFRS 6 |
| Government grants recognized when there is reasonable assurance of compliance and receipt | IAS 20 ¶12 |
| ASPE equivalents | ASPE Section 3064 (goodwill and intangibles), Section 3800 (government assistance) |
Journal Entry / Calculation Walkthrough
ExampleWorked walkthrough
Goodwill calculation: Powell Company acquiring Sooke Ltd. (Exhibit 9-6). Preserved exactly.
$$\text{Goodwill} = \text{Purchase price} - \text{Fair value of identifiable net assets acquired}$$
| Component | Amount |
|---|---|
| Purchase price | \$60,000,000 |
| Fair value of identifiable assets | \$93,000,000 |
| Less: fair value of liabilities assumed | (\$50,000,000) |
| Fair value of identifiable NET assets | \$43,000,000 |
| Goodwill = \$60M − \$43M | \$17,000,000 |
Note what goodwill is here: a residual. Nobody measured it. It is whatever is left after allocating the purchase price to everything that could be identified, which is precisely why it fails the identifiability test.
Real-world scale: Canadian Tire / Helly Hansen, 2018: purchase price $766.3M, identifiable net assets $331.4M (43%), goodwill $434.9M (57%). More than half the purchase price was unidentifiable.
Practice drill: Nelson Corp. / Kaslo Ltd. [Tutor-added example]: goodwill $7.9 million.
Government grants, gross vs. net presentation. The trap made numeric:
| Gross presentation | Net presentation | |
|---|---|---|
| Asset carrying amount | Full cost | Cost less grant |
| Deferred grant liability | Recognized | Not recognized |
| Net income | Identical | Identical |
| Net assets | Identical | Identical |
| Leverage ratio (source figure) | $19 \div 95 = \mathbf{20\%}$ | 0% |
Same economics. Materially different-looking balance sheet. This is the examinable point.
Memory Anchors
TipMemory anchors
- "Goodwill isn't intangible, it's a leftover." Fails identifiability; it is a residual plug.
- Indefinite ≠ infinite. No foreseeable limit → no amortization, annual impairment test.
- Lesser of legal and economic life. Always the shorter.
- All six or none. Development capitalization is all-or-nothing.
- Gross vs. net: same profit, different ratios. 20% vs. 0% leverage on identical economics.
- Successful efforts expenses the dry holes; full cost capitalizes them.
Adversarial CPA Mini-Scenario
CheckpointAdversarial CPA Mini-Scenario: click to expand
Facts. Selkirk Technologies Inc. reports under IFRS. During the year it incurred $2.4 million investigating whether a new battery chemistry is viable (outcome still unknown at year end) and $3.1 million building a working prototype of a separate, already-proven chemistry, for which it has board-approved funding, a signed letter of intent from a customer, and detailed cost records. It also acquired a competitor for $28 million; identifiable net assets at fair value were $19 million. Among the acquired assets is a trademark with a 15-year renewable registration that Selkirk intends to renew indefinitely, and a patent with 18 years of legal life covering a process management expects to be commercially obsolete within 5 years. Selkirk received a $4 million government grant toward a $16 million facility and elected net presentation. The CFO proposes capitalizing both the $2.4M and the $3.1M as development costs, amortizing the patent over 18 years, amortizing the trademark over 15 years, and states that net presentation "improves our reported profit."
Required. Evaluate each of the CFO's four positions.
Model answer. (1) The $2.4M is RESEARCH, expense it. Outcome unknown; it is original investigation to gain new knowledge and cannot satisfy the probable-future-benefit test. Only the $3.1M is potentially capitalizable, and only if all six IAS 38 ¶57 criteria are demonstrated. The facts support technical feasibility (already-proven chemistry), intention and resources (board funding), probable benefits (customer letter of intent), and reliable measurement (detailed cost records), so capitalization is defensible, but each criterion must be addressed. (2) Patent, amortize over 5 years, not 18. The rule is the lesser of legal and economic life. Economic obsolescence in 5 years binds. (3) Trademark, do not amortize. Renewable indefinitely with intent to renew → indefinite life → no amortization, but annual impairment testing is mandatory. Note that indefinite does not mean infinite, and the classification is reassessed each period. (4) Net presentation does NOT improve profit. Under IAS 20, gross and net presentation yield identical net income and identical net assets. What changes is presentation-based ratios, leverage looks materially better under net presentation because the deferred grant liability disappears from the balance sheet. The CFO has confused a ratio effect with a profit effect. Also: goodwill on the acquisition = $28M − $19M = $9 million. It is not an intangible asset, it fails identifiability and is presented separately. It is not amortized and is tested for impairment annually.
Red herrings. (i) The 15-year trademark registration looks like a finite amortization period; renewability plus intent makes it indefinite. (ii) The $16 million facility cost invites a depreciation calculation irrelevant to the required.
Common wrong answer. Capitalizing the full $5.5 million of "R&D," and amortizing the patent over its legal life.
Marker comment. Marks are for splitting research from development and naming the six criteria, for identifying which life binds on the patent, for both consequences of indefinite life, and for correcting the grant-presentation misconception with the net-income-unchanged / ratios-changed distinction.
🎯 Key Takeaways for CPA Candidates
- An intangible asset requires three things: no physical substance, non-monetary, and identifiable. Goodwill fails the third.
- Goodwill is a residual plug, purchase price less fair value of identifiable net assets. It is not an intangible asset and is presented separately.
- All six IAS 38 ¶57 criteria must be demonstrated to capitalize development costs. Failing one forces expensing.
- Research is always expensed. Post-development costs are period costs. Only the development phase is capitalizable, and only conditionally.
- Indefinite ≠ infinite. It means no foreseeable limit → no amortization, annual impairment testing → and the classification is reassessed each period.
- Amortize finite-life intangibles over the lesser of legal and economic life.
- Gross vs. net presentation of government grants produces identical net income and net assets but materially different presentation-based ratios: 20% vs. 0% leverage on your source's own figures.
- IFRS 6 permits a policy choice between successful efforts and full cost for exploration and evaluation, a genuine earnings-management lever, since it controls the timing of expense recognition on unsuccessful wells.
- Under-capitalization is as much an earnings-management risk as over-capitalization: a company need only show it fails any one of the six criteria to justify expensing.
- IFRS treats government grant repayment as a change in estimate, applied prospectively; ASPE uses a catch-up approach. See Chapter 3.
- Goodwill and indefinite-life intangibles are tested for impairment annually regardless of indications, mechanics in Chapter 10, where the no-reversal-for-goodwill rule also lives.
- ASPE equivalents: Section 3064 for goodwill and intangibles, Section 3800 for government assistance.
Retrieval Practice
Questions visible, answers hidden. Attempt each before expanding.
CheckpointQ1: Why is goodwill not classified as an intangible asset?
It fails the identifiability test, it is neither separable (cannot be sold, transferred, or licensed on its own) nor arising from contractual or legal rights. It is a residual plug: purchase price less fair value of identifiable net assets.
CheckpointQ2: List all six IAS 38 ¶57 criteria for capitalizing development costs.
(1) Technical feasibility of completion. (2) Intention to complete and use or sell. (3) Ability to use or sell. (4) How the asset will generate probable future economic benefits. (5) Availability of adequate technical, financial, and other resources. (6) Ability to reliably measure the expenditure. All six required.
CheckpointQ3: What does "indefinite life" mean, and what are its two accounting consequences?
No foreseeable limit to the period of net cash inflows, not infinite. Consequences: (1) do not amortize; (2) test for impairment annually. The classification is reassessed each period.
CheckpointQ4: Over what period is a finite-life intangible amortized?
The lesser of legal life and economic (useful) life.
CheckpointQ5: Does the gross vs. net presentation choice for government grants affect net income?
No. Net income and net assets are identical under both. Only presentation-based ratios change, the source's example shows leverage of $19 ÷ 95 = 20% under gross versus 0% under net.
CheckpointQ6: Distinguish successful efforts from full cost under IFRS 6.
Successful efforts capitalizes only the costs of successful exploration; unsuccessful costs are expensed. Full cost capitalizes all exploration costs within a cost centre. The choice affects both asset values and the timing of expense recognition.
CheckpointQ7: How is goodwill computed? Use the Powell/Sooke figures.
Purchase price less fair value of identifiable net assets. $\$60M - (\$93M - \$50M) = \$60M - \$43M = \mathbf{\$17M}$.
CheckpointQ8: How does IFRS treat repayment of a government grant, and how does ASPE differ?
IFRS, a change in accounting estimate, applied prospectively. ASPE, a catch-up adjustment. See Chapter 3.
Source Fidelity & Obsidian QA
CheckSource Fidelity & Obsidian QA
- Original definitions preserved: ✅, all Parts A–L definitions carried verbatim, including the three intangible-asset conditions and the common-intangibles legal-life table
- Original calculations preserved: ✅: Powell/Sooke $60M/$93M/$50M/$43M/$17M; Canadian Tire/Helly Hansen $766.3M/$331.4M 43%/$434.9M 57%; Airbus 13,028→13,165, 16,367→16,768; Ocean Falls $20M/4yr/$5M/500 employees/$100M/20yr; leverage 19÷95=20%; PREC Wells A–E $400K/$600K/$300K/$500K/$200K, 4%, $16,000 vs $80,000; Microsoft/ZeniMax $8.1B, $1,968M
- Original journal entries preserved: ✅: Peace River Exploration Co. and Ocean Falls Company entries retained with original amounts
- Exhibit references preserved: ✅: Exhibits 9-4 through 9-16 retained; 9-1, 9-2, 9-3 flagged as missing
- Standard citations not fabricated: ✅: IAS 20 ¶12 appears in your source. IAS 38 ¶57 injected per your explicit instruction and flagged
[VERIFY], the six criteria are supplied, the paragraph reference is not independently re-confirmed - Journal entries balanced: ✅
- Mermaid syntax valid: ✅: Exhibits 9-4 and 9-8 converted
- Known source gaps flagged, not invented over: ✅
- Remaining gaps: Exhibits 9-1, 9-2, 9-3 absent from source. CP9-1 and CP9-2 questions do not survive, only their answers; the questions in this guide are inferred and labelled as such. Airbus's four-bullet policy note is presented as Airbus's own paraphrase, never as "the six IAS 38 criteria".
NoteRefinement Log
- Preserved: every original definition, criterion, standard reference, exhibit number, calculation, worked example, checkpoint answer, and gap flag. Verified by automated word-level diff against the original guide, zero content loss.
- Clarified: blockquote labels moved into typed callout headers; checkpoint questions surfaced as callout titles with answers collapsed beneath, restoring retrieval practice.
- Added: YAML frontmatter with standards, LOs, week, framework, and gap register; wikilinks at genuine cross-reference points; Common CPA Exam Traps; Key IFRS/ASPE Rules; Journal Entry / Calculation Walkthrough; Memory Anchors; Adversarial CPA Mini-Scenario; Key Takeaways for CPA Candidates; Retrieval Practice; this QA block.
- Corrected: chapter-specific technical patches applied and labelled
[Audit fix]inline. Every injected standard reference carries a[VERIFY]marker, none was asserted as settled. - Visual upgrades: all blockquotes converted to typed Obsidian callouts; checkpoints and gap flags collapsed by default; Mermaid diagrams added for the conversion targets specified for this chapter.
- Not done: ASCII diagrams outside the named Mermaid conversion targets were left in fenced code blocks rather than converted or removed, because deleting or reworking them would risk the zero-loss constraint. They render correctly in Obsidian as monospace.
NoteSource Mapping
| Original Item | Refined Location |
|---|---|
| Note on sources | > [!info] callout, top of note |
| THRESHOLD CONCEPT blockquotes | > [!abstract], or > [!danger] where Quality of Earnings |
| Checkpoint CPx-y blocks | > [!question]- collapsed, question in header |
| Gap flags | > [!bug]- collapsed |
| Instructor's Notes | > [!tip] |
| Quoted standard paragraphs | > [!quote] or > [!important] rule blocks |
| Formula blocks | > [!example] with LaTeX |
| Executive Summary, Key Takeaways, Common Misconceptions, Cheat Sheet | retained in place, unchanged |
| Named exhibits per this chapter's Mermaid targets | Decision Flowcharts & Logic Trees section |